HIP DYSPLASIA side effect
What is HIP DYSPLASIA ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
HIP DYSPLASIA and Recently Reported Side Effects
HIP DYSPLASIA and 15 most Active Side Effect polls
HIP DYSPLASIA and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with HIP DYSPLASIA
ARIMIDEX ATRIPLA AVONEX CARBAMAZEPINE FLOVENT KALETRA KEPPRA MEBENDAZOLE SINGULAIR STOCRIN TELFAST TOPAMAX TOPIRAMATE TRIZIVIR VIRAMUNE VIREAD ZIDOVUDINEAtripla Side Effects Report #5647705-2
Consumer or non-health professional from UNITED STATES reported ATRIPLA problem on Feb 22, 2008. Female patient, weighting 4.60 lb, was treated with ATRIPLA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . ATRIPLA dosage: 600/200 MILLIGRAM. During the same period patient was treated with TRUVADA, NEVIRAPINE, KALETRA, TRIZIVIR. Patient recovered.
Atripla Side Effects Report #5647708-8
ATRIPLA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2008. Male patient, weighting 4.70 lb, was treated with ATRIPLA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . ATRIPLA dosage: 600/200 MILLIGRAM. During the same period patient was treated with TRUVADA, NEVIRAPINE, KALETRA, TRIZAVIR. Patient recovered.
Viramune Side Effects Report #5647819-7
Physician from UNITED STATES reported VIRAMUNE problem on Feb 22, 2008. Male patient, weighting 4.63 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . VIRAMUNE dosage: unknown. During the same period patient was treated with ATRIPLA, TRUVADA, KALETRA, TRIZIVIR. Patient recovered.
Viread Side Effects Report #5669500-0
VIREAD problem was reported by a Health Professional from UNITED STATES on Mar 05, 2008. Male patient, weighting 4.19 lb, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, pulmonary valve stenosis, . VIREAD dosage: unknown. During the same period patient was treated with EMTRIVA, EFAVIRENZ. Patient recovered.
Stocrin Side Effects Report #5673146-8
Health Professional from UNITED STATES reported STOCRIN problem on Mar 11, 2008. Male patient, weighting 1900 lb, was diagnosed with hiv infection and was treated with STOCRIN. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, pregnancy, pulmonary valve stenosis, . STOCRIN dosage: unknown. During the same period patient was treated with EMTRIVA, VIREAD. Patient recovered.
Viramune Side Effects Report #5580798-X
VIRAMUNE problem was reported by a Physician from UNITED STATES on Dec 27, 2007. Male patient, weighting 4.63 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . VIRAMUNE dosage: unknown. During the same period patient was treated with ATRIPLA, TRUVADA, KALETRA, TRIZIVIR. Patient recovered.
Viramune Side Effects Report #5580800-5
Physician from UNITED STATES reported VIRAMUNE problem on Dec 27, 2007. Female patient, weighting 4.63 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . VIRAMUNE dosage: unknown. During the same period patient was treated with ATRIPLA, TRUVADA, KALETRA, TRIZIVIR. Patient recovered.
Atripla Side Effects Report #5585401-0
ATRIPLA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 28, 2007. Male patient, weighting 4.70 lb, was treated with ATRIPLA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . ATRIPLA dosage: 600/200 MILLIGRAM. During the same period patient was treated with TRUVADA, NEVIRAPINE, KALETRA, TRIZAVIR. Patient recovered.
Atripla Side Effects Report #5585402-2
Consumer or non-health professional from UNITED STATES reported ATRIPLA problem on Dec 28, 2007. Female patient, weighting 4.60 lb, was treated with ATRIPLA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . ATRIPLA dosage: 600/200 MILLIGRAM. During the same period patient was treated with TRUVADA, NEVIRAPINE, KALETRA, TRIZIVIR. Patient recovered.
Atripla Side Effects Report #5593900-0
ATRIPLA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 09, 2008. Male patient, weighting 4.70 lb, was treated with ATRIPLA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . ATRIPLA dosage: 600/200 MILLIGRAM. During the same period patient was treated with TRUVADA, NEVIRAPINE, KALETRA, TRIZAVIR. Patient recovered.
Atripla Side Effects Report #5593901-2
Consumer or non-health professional from UNITED STATES reported ATRIPLA problem on Jan 09, 2008. Female patient, weighting 4.60 lb, was treated with ATRIPLA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . ATRIPLA dosage: 600/200 MILLIGRAM. During the same period patient was treated with TRUVADA, NEVIRAPINE, KALETRA, TRIZIVIR. Patient recovered.
Kaletra Side Effects Report #5377798-1
KALETRA problem was reported by a Health Professional from UNITED STATES on June 27, 2007. Female patient, weighting 7.21 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, ZIDOVUDINE. Patient recovered.
Kaletra Side Effects Report #5379342-1
Health Professional from BELGIUM reported KALETRA problem on June 26, 2007. Female patient, weighting 7.33 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . KALETRA dosage: unknown. Patient recovered.
Kaletra Side Effects Report #5377798-1
KALETRA problem was reported by a Health Professional from UNITED STATES on June 27, 2007. Female patient, weighting 7.21 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, ZIDOVUDINE. Patient recovered.
Kaletra Side Effects Report #5379342-1
Health Professional from BELGIUM reported KALETRA problem on June 26, 2007. Female patient, weighting 7.33 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . KALETRA dosage: unknown. Patient recovered.
Stocrin Side Effects Report #5789908-2
STOCRIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2008. Male patient, weighting 1900 lb, was diagnosed with hiv infection and was treated with STOCRIN. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, pregnancy, pulmonary valve stenosis, . STOCRIN dosage: unknown. During the same period patient was treated with EMTRIVA, VIREAD. Patient recovered.
Atripla Side Effects Report #5738161-4
Consumer or non-health professional from UNITED STATES reported ATRIPLA problem on Feb 22, 2008. Male patient, weighting 4.70 lb, was treated with ATRIPLA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . ATRIPLA dosage: 600/200 MILLIGRAM. During the same period patient was treated with TRUVADA, NEVIRAPINE, KALETRA, TRIZAVIR. Patient recovered.
Atripla Side Effects Report #5738165-1
ATRIPLA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2008. Female patient, weighting 4.60 lb, was treated with ATRIPLA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . ATRIPLA dosage: 600/200 MILLIGRAM. During the same period patient was treated with TRUVADA, NEVIRAPINE, KALETRA, TRIZIVIR. Patient recovered.
Singulair Side Effects Report #5694801-X
Physician from UNITED KINGDOM reported SINGULAIR problem on Mar 27, 2008. Female patient, weighting 6.61 lb, was treated with SINGULAIR. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, varicose ulceration, . SINGULAIR dosage: unknown. During the same period patient was treated with FEXOFENADINE HYDROCHLORIDE. Patient recovered.
Kaletra Side Effects Report #5324347-X
KALETRA problem was reported by a Health Professional from UNITED STATES on May 04, 2007. Female patient, weighting 7.21 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient recovered.
Topamax Side Effects Report #5258341-4
Health Professional from UNITED KINGDOM reported TOPAMAX problem on Feb 26, 2007. Female patient, weighting 7.08 lb, was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . TOPAMAX dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, CLOBAZAM, KEPPRA. Patient recovered.
Viramune Side Effects Report #5645693-6
VIRAMUNE problem was reported by a Physician from UNITED STATES on Feb 22, 2008. Female patient, weighting 4.41 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, premature baby, twin pregnancy, . VIRAMUNE dosage: unknown. During the same period patient was treated with ATRIPLA, TRUVADA, KALETRA, TRIZIVIR. Patient recovered.
Zidovudine Side Effects Report #5662076-3
Consumer or non-health professional from GERMANY reported ZIDOVUDINE problem on Feb 19, 2008. Female patient was diagnosed with antiviral prophylaxis and was treated with ZIDOVUDINE. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . ZIDOVUDINE dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient recovered.
Trizivir Side Effects Report #5583039-2
TRIZIVIR problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 28, 2007. Male patient, weighting 4.41 lb, was treated with TRIZIVIR. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . TRIZIVIR dosage: unknown. During the same period patient was treated with ATRIPLA, NEVIRAPINE, TRUVADA, KALETRA. Patient recovered.
Trizivir Side Effects Report #5583040-9
Consumer or non-health professional from UNITED STATES reported TRIZIVIR problem on Dec 28, 2007. Female patient, weighting 4.41 lb, was treated with TRIZIVIR. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . TRIZIVIR dosage: unknown. During the same period patient was treated with ATRIPLA, NEVIRAPINE, TRUVADA, KALETRA. Patient recovered.
Topiramate Side Effects Report #5599801-6
TOPIRAMATE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 03, 2008. Female patient was treated with TOPIRAMATE. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . TOPIRAMATE dosage: 100 MG TRANSPLACENTAL. During the same period patient was treated with CARBAMAZEPINE, LEVETIRACETAM, CLOBAZAM. Patient recovered.
Flovent Side Effects Report #5556008-6
Consumer or non-health professional from UNITED KINGDOM reported FLOVENT problem on Nov 20, 2007. Female patient was treated with FLOVENT. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, jaundice neonatal, ventricular septal defect, . FLOVENT dosage: unknown. Patient recovered.
Flovent Side Effects Report #5556017-7
FLOVENT problem was reported by a Physician from UNITED KINGDOM on Nov 20, 2007. Female patient was treated with FLOVENT. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . FLOVENT dosage: unknown. Patient recovered.
Arimidex Side Effects Report #5472598-6
Consumer or non-health professional from UNITED STATES reported ARIMIDEX problem on Oct 06, 2006. Female patient, 68 years of age, weighting 160.1 lb, was diagnosed with breast cancer and was treated with ARIMIDEX. After drug was administered, patient experienced the following problems/side effects: arthralgia, hip dysplasia, influenza like illness, oedema peripheral, . ARIMIDEX dosage: unknown. During the same period patient was treated with ATENOLOL, LISINOPRIL, HYDROCHLOROTHIAZIDE. Patient recovered.
Keppra Side Effects Report #5500142-3
KEPPRA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 09, 2007. Female patient was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . KEPPRA dosage: unknown. Patient recovered.
Kaletra Side Effects Report #5464495-7
Health Professional from UNITED STATES reported KALETRA problem on Sept 11, 2007. Female patient, weighting 7.21 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, ZIDOVUDINE. Patient recovered.
Telfast Side Effects Report #5696173-3
TELFAST problem was reported by a Physician from UNITED KINGDOM on Mar 28, 2008. Female patient, weighting 5.51 lb, was diagnosed with angioedema and was treated with TELFAST. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, varicose vein, . TELFAST dosage: unknown. During the same period patient was treated with MONTELUKAST. Patient recovered.
Carbamazepine Side Effects Report #5269462-4
Consumer or non-health professional from UNITED KINGDOM reported CARBAMAZEPINE problem on Feb 26, 2007. Female patient was diagnosed with epilepsy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: hip dysplasia, . CARBAMAZEPINE dosage: 1400 MG TRANSPLACENTAL. During the same period patient was treated with CLOBAZAM, LEVETIRACETAM, TOPIRAMATE. Patient recovered.
Avonex Side Effects Report #5379827-8
AVONEX problem was reported by a Consumer or non-health professional from on June 14, 2007. Female patient, weighting 6.61 lb, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: caesarean section, foetal distress syndrome, hip dysplasia, meconium in amniotic fluid, pregnancy of partner, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Avonex Side Effects Report #5379827-8
Consumer or non-health professional from reported AVONEX problem on June 14, 2007. Female patient, weighting 6.61 lb, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: caesarean section, foetal distress syndrome, hip dysplasia, meconium in amniotic fluid, pregnancy of partner, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Mebendazole Side Effects Report #5370093-6
MEBENDAZOLE problem was reported by a Physician from UNITED KINGDOM on June 15, 2007. Female patient, weighting 5.16 lb, was treated with MEBENDAZOLE. After drug was administered, patient experienced the following problems/side effects: arthritis reactive, arthropathy, hip dysplasia, strabismus, upper respiratory tract infection, . MEBENDAZOLE dosage: unknown. Patient recovered.